[Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].

Document type:: Journal Article; Editorial Material
Author(s):: Ohlmann, C-H; Miller, K; Gschwend, J
Title:: [Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
Journal title abbreviation:: Urologe A
Year:: 2017
Journal volume:: 56
Journal issue:: 9
Pages contribution:: 1185-1186
Language:: de
Fulltext / DOI:: doi:10.1007/s00120-017-0464-7
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/28733874
Print-ISSN:: 0340-2592
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: